Cover Image

Patient-reported outcome instruments used in immune-checkpoint inhibitor clinical trials in oncology: a systematic review

Abstract Context Immune-checkpoint inhibitors (ICI) have shown significant benefits for overall survival across various cancer types. Patient-reported outcomes (PROs) are assessed in clinical trials as a measure of efficacy. However, it remains unclear to what extent current PRO instruments capture...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sara Colomer-Lahiguera (Author), Denise Bryant-Lukosius (Author), Sarah Rietkoetter (Author), Lorraine Martelli (Author), Karin Ribi (Author), Donna Fitzpatrick-Lewis (Author), Diana Sherifali (Author), Angela Orcurto (Author), Rosalyn Juergens (Author), Manuela Eicher (Author)
Format:	Book
Published:	SpringerOpen, 2020-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Reflections on the opportunities and challenges of applying experience‐based co‐design (EBCD) to phase 1 clinical trials in oncology
by: Nils Graber, et al.
Published: (2024)

The Glycosylation of Immune Checkpoints and Their Applications in Oncology
by: Linlin Zheng, et al.
Published: (2022)

Stakeholder Engagement in Nursing Curriculum Development and Renewal Initiatives: A Review of the Literature
by: Emily Belita, et al.
Published: (2020)

Mechanistic basis for Cancer Immune Evasion and role of immune checkpoint blockades in Immuno-Oncology
by: Benjamin A Babalola, et al.
Published: (2021)

Hepatobiliary complications of immune checkpoint inhibitors in cancer
by: Donna Zhuang, et al.
Published: (2024)

Personalized symptom management: a quality improvement collaborative for implementation of patient reported outcomes (PROs) in 'real-world' oncology multisite practices
by: Doris Howell, et al.
Published: (2020)

Nurses' adaptation instrument in the oncology wards: Development and psychometric testing
by: Shahrzad Ghiyasvandian, et al.
Published: (2020)

Real‐world treatment outcomes of immune checkpoint inhibitors used off‐label in oncology: A comprehensive cancer institution experience
by: Sandra Fontanals, et al.
Published: (2024)

Characterization and evaluation of dermatological immune-mediated reactions associated with checkpoint inhibitors: an observational, longitudinal and retrospective study in an oncology service in Salvador/BA
by: Leonardo Bonfim ALMEIDA, et al.
Published: (2024)

Experiences of cancer care during COVID-19: Phase 1 results of a longitudinal qualitative study
by: Amanda Drury, et al.
Published: (2021)

A reflection checkpoint
by: Francisco José GARCÍA PEÑALVO
Published: (2015)

Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis
by: Shuo Zhang, et al.
Published: (2021)

Construct validity of advanced practice nurse core competence scale: an exploratory factor analysis
by: Sek Ying Chair, et al.
Published: (2023)

Communication about environmental health risks: A systematic review
by: Ciliska Donna, et al.
Published: (2010)

Community-based interventions for enhancing access to or consumption of fruit and vegetables among five to 18-year olds: a scoping review
by: Ganann Rebecca, et al.
Published: (2012)

Advanced Practice Nursing: A Strategy for Achieving Universal Health Coverage and Universal Access to Health
by: Denise Bryant-Lukosius, et al.

Local delivery of checkpoints antibodies
by: Chao Wang, et al.
Published: (2017)

Development and validation of an instrument to assess the knowledge of oncology nurses about a fully implanted catheter
by: Jamile Mineu Pereira, et al.
Published: (2022)

Immune Checkpoint Inhibitors New Insights and Recent Progress
Published: (2023)

Immune Checkpoint Molecules and Cancer Immunotherapy
by: Alexandr V. Bazhin
Published: (2019)

Skin manifestations associated with checkpoint inhibitors
by: Gianluca Nazzaro, et al.
Published: (2022)

Immune Checkpoint in Glioblastoma: Promising and Challenging
by: Jing Huang, et al.
Published: (2017)

The gut microbiota and immune checkpoint inhibitors
by: Audrey Humphries, et al.
Published: (2018)

The role of immune checkpoints in cardiovascular disease
by: Laura I. Yousif, et al.
Published: (2022)

Cardiovascular complications of immune checkpoint inhibitors
by: A. A. Kulievа, et al.
Published: (2020)

Immune Checkpoint Inhibitors and Lupus Erythematosus
by: Hans Vitzthum von Eckstaedt, et al.
Published: (2024)

Validation of a short Spanish version of the instrument Barriers to Physical Activity Questionnaire for People with Mobility Impairments
by: Joan Úbeda-Colomer, et al.
Published: (2018)

Pulmonary Toxicities Associated With the Use of Immune Checkpoint Inhibitors: An Update From the Immuno-Oncology Subgroup of the Neutropenia, Infection & Myelosuppression Study Group of the Multinational Association for Supportive Care in Cancer
by: Bernardo L. Rapoport, et al.
Published: (2021)

Instruments to measure the quality of life in patients with oral mucositis undergoing oncological treatment: a systematic review of the literature
by: Rosaura Gutiérrez-Vargas, et al.
Published: (2016)

Inequalities in patients' experiences with cancer care: the role of economic and health literacy determinants
by: Vladimir Jolidon, et al.
Published: (2024)

Prediction of posttraumatic stress in fathers of children with chronic diseases or unintentional injuries: a six-months follow-up study
by: Sennhauser Felix H, et al.
Published: (2007)

Skin Manifestation Induced by Immune Checkpoint Inhibitors
by: Yamamoto T
Published: (2022)

Immune Checkpoint Inhibitors in Melanoma: Review and Update
by: Eugénia Matos Pires, et al.
Published: (2018)

Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics
by: Michael Macklin, et al.
Published: (2023)

Checkpoints and immunity in cancers: Role of GNG12
by: Abdullahi Alausa, et al.
Published: (2022)

Nephrotoxicity of checkpoint inhibitors; a current challenge
by: Samaneh Zandifar, et al.
Published: (2024)

Immune Checkpoint Inhibitors in Peripheral T-Cell Lymphoma
by: Xi Chen, et al.
Published: (2022)

Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies
by: Katarina Hradska, et al.
Published: (2021)

Clinical Insights Into Novel Immune Checkpoint Inhibitors
by: Jii Bum Lee, et al.
Published: (2021)

Resistance to immune checkpoint inhibitors in gastric cancer
by: Kai Liu, et al.
Published: (2023)